Ablynx burns more cash in first half of 2015

August 27, 2015 6:03 AM

27 0

BRUSSELS Aug 27 Belgian biotech firm Ablynx burnt through more cash in the first half of 2015, as it increased spending on research and clinical trials for its experimental drugs.

The group, which makes treatments based on nanobodies, small antibodies found in llamas and alpacas, said it used up 35 million euros ($39.7 million) of cash in the first half of 2015.

Also read: Why Cash Returning From Overseas Isn’t Likely to Create Jobs—and Might Even Reduce Them

Read more

To category page